Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
43.90
+0.10 (0.23%)
Mar 5, 2026, 1:30 PM CST

Orient EuroPharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,8084,1813,3743,1403,1534,173
Market Cap Growth
-9.95%23.91%7.46%-0.41%-24.43%-13.49%
Enterprise Value
5,6408,2677,2746,4275,2925,012
Last Close Price
43.9047.3537.4534.8534.1243.48
PE Ratio
--23.44-26.2420.94
PS Ratio
0.840.950.740.660.660.78
PB Ratio
0.480.720.810.910.911.07
P/TBV Ratio
0.560.820.971.091.101.34
P/FCF Ratio
-----11.10
P/OCF Ratio
--52.18-40.616.86
EV/Sales Ratio
1.241.881.581.361.110.93
EV/EBITDA Ratio
149.3553.8730.85913.2387.7218.01
EV/EBIT Ratio
--103.01--42.71
EV/FCF Ratio
-24.69----13.34
Debt / Equity Ratio
0.360.731.161.461.220.62
Debt / EBITDA Ratio
30.7321.1516.88112.2144.257.65
Debt / FCF Ratio
-----6.40
Net Debt / Equity Ratio
0.100.450.710.920.630.02
Net Debt / EBITDA Ratio
15.4717.0712.49447.9536.160.29
Net Debt / FCF Ratio
-3.49-11.90-84.82-3.67-1.470.21
Asset Turnover
0.370.390.430.480.540.67
Inventory Turnover
2.032.102.002.262.152.10
Quick Ratio
1.100.750.730.690.821.18
Current Ratio
1.651.201.141.101.221.78
Return on Equity (ROE)
-5.86%-4.63%4.45%-8.57%2.02%2.77%
Return on Assets (ROA)
-0.52%-0.04%0.42%-0.94%-0.68%0.92%
Return on Invested Capital (ROIC)
-1.20%-0.09%0.68%-2.44%-1.74%1.23%
Return on Capital Employed (ROCE)
-1.10%-0.10%1.00%-2.30%-1.60%2.00%
Earnings Yield
-12.16%-6.79%4.27%-9.90%3.81%4.78%
FCF Yield
-6.00%-5.27%-1.03%-27.32%-47.10%9.01%
Dividend Yield
2.28%2.11%2.67%-2.49%3.45%
Payout Ratio
----108.28%78.35%
Buyback Yield / Dilution
0.23%0.23%-0.23%0.24%0.21%-0.07%
Total Shareholder Return
2.50%2.34%2.44%0.24%2.70%3.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.